SlideShare a Scribd company logo
1 of 26
MONOCLONAL ANTIBODY=singal type of antibody
,directed against specific epitope.
POLYCLONAL ANTIBODY=in response to an
antigen(with several different epitopes),B cells
gear up and produce many different
antibodies.this type of antibody which can react
with same antigen are called as polyclonal
antibodies.
 B-CELLS+MYLEOMA=HYBRIDOMA
andThe production of monoclonal antibodies
by the hybrid cells is referred to as
hybridoma technology.
Georges Kohler
CesarMilstein
Niels Jerne
The production of monoclonal
antibodies was invented by
Cesar Milstein and Georges
Kohler in 1975.they shared the
nobel prize of 1984 for medicine
and physiology with Neils Jerne,
who made other contribution to
immunology and the term
hybridoma was coined by
leonard herzenberg in Cesar
Milstein’s laboratory in
1976/1977
Antibody producing lymphocyte B cell are isolated from the
spleen cell of mouse immunized against a specific antigen
Single myeloma cell is a bone marrow tumour cells of
multiplying indefinitely.
Fused hybrid cells or hybridoma have the antibody producing
capability inherited from lymphocytes and have the ability to
grow continuously or immortal like malignant cancer cells.
1. Immunization of a mouse
2. Isolation of B cells from the spleen
3. Cultivation of myeloma cells
4. Fusion of myeloma and B cells
5. Separation of cell lines
6. Screening of suitable cell lines
7. in vitro (a) or in vivo (b) multiplication
8. Harvesting
1. Immunize a rabbit through repeated
injection of a specific antigen for the
production of specific antibody, facilitated
due to proliferation of the desired B cells.
2. Produce tumors in a mouse or a rabbit.
3. Culture separately the spleen cells that
produce specific antibodies and the
myeloma cells that produce tumors
4. Myeloma cells cannot synthesize antibodies
as they lack HGPRT gene required for the
synthesize the enzyme, hypoxanthine
guanine phosphoribosyl transferase
• Fusion of spleen cells to myeloma cells is
induced using polyethylene glycol (PEG), to
produce hybridoma
• Hybridomas are grown in selective
hypoxanthine aminopterin thymidine (HAT)
medium.
• HAT medium contains a drug, aminopterin
that blocks one pathway for nucleotide
synthesis, making the cells dependent on
another pathway that needs HGPRT enzyme,
which is absent in myeloma cells.
• Myeloma cells that do not fuse with B cells
will die.
• B cells that do not fuse will also die because
they lack tumorigenic property of immortal
growth.
 Select desired hybridoma for cloning and antibody
production
 Prepare single cell colonies that can grow and use
them to screen of antibody producing hybridomas
 Only one in several hundred cell hybrids will produce
antibodies of the desired specificity
 Culture selected hybridoma cells for the production of
monoclonal antibodies in large quantities
 Hybridoma cells can be frozen for future use or can be
injected in the body of an animal, so that antibodies
will be produced in the body and recovered later from
the body fluid.
Monoclonal antibody truely represent a
homogeneous state of a single molecular
species.
Each monoclonal antibody is specific for a
given antigenic determinant
and there are wide range of aaplications of
monoclonal antibodies.
It is possible to select for specific epitope
specifities and generate antibodies against a
wider range of antigenic determinants.
 Hybridoma technology is laborious and time
consuming.
 Mabs are produced against a single antigenic
determinant ,hence they do not differentiate the
molecule as a whole . Sometime they may be
incapable of distinguishing groups of different
molecule also.
 Mice used in Mab production carry several
viruses(adeno viruses ,hepatic viruses).the
presence of these viruses has been detected in
hybridomas.this posses a great danger there is
no guarantee that Mab is totally virus free,
despite the purification .
 Diagnosis of HIV virus
 The test of HIV
infection is based on
detecting the presence
of HIV antibody in the
patient’s blood serum
a) HIV antigen is attached to the plate.
b) Patients serum passed over the plate. Any HIV
antibody in the patients serum will attached to the
antigen already on the plate.
c) A second antibody which is specific to the HIV
antibody is passed over the plate. This antibody
will attach to the concentrated HIV antibody on
the plate. This second antibody has an enzyme
attached to its structure.
d) Chromagen dye is passed over the complex of
concentrated HIV antibody/conjugated antibody.
e) The enzyme will turn the chromagen to a more
intense colour. The more intense the colour, the
greater the HIV antibody level. This would be the
a positive result for a HIV test.
 Identification of ABO blood groups.
 Detection of pregnancy by assaying of
hormones with monoclonals,antibodies.
 Detection of pathogen.
 Separation of one substance from a mixture
of very simmilar molecules .
monoclonal antibodies are used in the
diagnostic immaging of diseases,and this
technique is referred as immunoscintigraphy.
Monoclonal antibodies use as immunotoxins-
toxins +Mabs=immunotoxins ,used in therapy.
RICIN- derived from castor oil plant,composed
of two polypeptide chains( A and B),held
together by disulfide linkage.
The B chain of ricin bind to the cell
surface.this binding facilitates the A chain of
ricin to enter the cell and inhibit the
function of ribosomes(i.e. Biosynthesis of all
protein is blocked).this result in death of
cells.
 RICIN can be subjected to oxidation to
separate to A and B chains. The toxic A chain
can be conjugated to Mab that is specific to
cancer cells.
 The tumor specific Mab bound to A chain of
ricin binds to cancer cells and not to normal
cells . Once the A chain enters the cells ,it
blocks ribosomal functions leading to the
death of cancer cells.
 Monoclonal antibody in drug delivery-the drugs can
be coupled with monoclonal antibody(directed
against a cell surface antigen of the cells,say a tumor
) and specifically targetted to reach the site of
action.
 In the treatment of certain diseases ,a prodrug(an
inactive form of drug)can be used.this can be
enzymatically converted to active drug inthe target
tissues.the enzyme that convert prodrug to drug is
coupled with Mab.that is directed against a specific
cell surface antigen this approach is referred as
antibody directed pro drug therapy(ADEPT).e.g
alkaline phosphatase used for the conversion of
phosphate drugs.
A great majority of natural death are due to a
blockage in coronary or cerebral artery by a
blood clot (Thrombus).fibrin is a major
constituent of blood clot which get dissolved
by plasmin.
Plasmin in turn is form by the activation of
plasminogen by plasminogen activator.
monoclonal antibody directed against fibrin
can be coupled to tissue plasminogen
activator and used for degradation of blood
clot .
 The radioisotope can be coupled to monoclonal
antibodies that ae directed againsttumor cells this
allows the cocentration of radioactivity at desired
site and very efficient killing of target cells (tumor
cells).
 The advantage with radioimmunotherapy is that
conjugated complex need not penetrate the cells,as
is required in immunotoxin therapy disadvantage is
that neighbouring normal cells also get damaged or
killed.
 This can be minimised by using radioisotope with
short half lives .yttrium -90 with a half life span of
64hrs. Due to shortage in supply of yttrium,indium
111 is more commonly used and they should have half
life and decay bi-product should be inert.
 By using affinity chromatography technique
Mabs can be used for the purification of
protein e.g.fetoprotein and interferon.
 Identification of previously unknown antigen.
 Fluorescent labelled Mabs are used for
identification ,isolation of cells displaying a
specific antigen on their surface.
 Mabs have been used to isolate mRNAs
encoding the protein to which Mabs are
specific.
 The antibody enzymes ,appropriately
regarded as abzymes ,are catalytic
antibodies.
 It should be possible to generate such
abzymes that catalyze reactions for which no
natural enzyme exist.
Hybridoma .pptx

More Related Content

Similar to Hybridoma .pptx

MONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONS
MONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONSMONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONS
MONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONSSaajida Sultaana
 
hybridoma technology.pptx
hybridoma technology.pptxhybridoma technology.pptx
hybridoma technology.pptxTejaswiniAsawa
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodiesShadab Khan
 
Monoclonal antibodies explanation .pptx
Monoclonal antibodies explanation  .pptxMonoclonal antibodies explanation  .pptx
Monoclonal antibodies explanation .pptxUVAS
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodiesMicBio3
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technologyRitesh ranjan
 
Hybridoma Technology.pptx
Hybridoma Technology.pptxHybridoma Technology.pptx
Hybridoma Technology.pptxShafiquRahman2
 
Monoclonal antibodies
Monoclonal   antibodiesMonoclonal   antibodies
Monoclonal antibodiesPV. Viji
 
Monoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technologyMonoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technologyAjay Dominic
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
Monoclonal antibodies preparatation and applicatation
Monoclonal antibodies preparatation and applicatationMonoclonal antibodies preparatation and applicatation
Monoclonal antibodies preparatation and applicatationSUJITHA MARY
 
Presentation 0 n hybridoma technology
Presentation 0 n hybridoma technologyPresentation 0 n hybridoma technology
Presentation 0 n hybridoma technologyVipin Shukla
 
Monoclonal antibodies Clinical Significance
Monoclonal antibodies Clinical SignificanceMonoclonal antibodies Clinical Significance
Monoclonal antibodies Clinical Significancedrvicky666
 
Hybridomatechnology 160204054435
Hybridomatechnology 160204054435Hybridomatechnology 160204054435
Hybridomatechnology 160204054435ANU RAJ
 
Monoclonal antibody, Application of Monoclonal Antibody, Uses
Monoclonal antibody, Application of Monoclonal Antibody, Uses Monoclonal antibody, Application of Monoclonal Antibody, Uses
Monoclonal antibody, Application of Monoclonal Antibody, Uses KundanSable1
 
Hybridoma technology
Hybridoma technology Hybridoma technology
Hybridoma technology Saikat Mondal
 

Similar to Hybridoma .pptx (20)

MONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONS
MONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONSMONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONS
MONOCLONAL ANTIBODIES-HYBRIDOMA TECHNOLOGY-APPLICATIONS
 
hybridoma technology.pptx
hybridoma technology.pptxhybridoma technology.pptx
hybridoma technology.pptx
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Monoclonal antibodies explanation .pptx
Monoclonal antibodies explanation  .pptxMonoclonal antibodies explanation  .pptx
Monoclonal antibodies explanation .pptx
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
Hybridoma Technology.pptx
Hybridoma Technology.pptxHybridoma Technology.pptx
Hybridoma Technology.pptx
 
Monoclonal antibodies
Monoclonal   antibodiesMonoclonal   antibodies
Monoclonal antibodies
 
Monoclonal antibodies and gene therpy
Monoclonal antibodies and gene therpyMonoclonal antibodies and gene therpy
Monoclonal antibodies and gene therpy
 
Monoclinal antibodies and gene therapt 1
Monoclinal antibodies and gene therapt 1Monoclinal antibodies and gene therapt 1
Monoclinal antibodies and gene therapt 1
 
Monoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technologyMonoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technology
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
Monoclonal antibodies preparatation and applicatation
Monoclonal antibodies preparatation and applicatationMonoclonal antibodies preparatation and applicatation
Monoclonal antibodies preparatation and applicatation
 
Presentation 0 n hybridoma technology
Presentation 0 n hybridoma technologyPresentation 0 n hybridoma technology
Presentation 0 n hybridoma technology
 
Monoclonal antibodies Clinical Significance
Monoclonal antibodies Clinical SignificanceMonoclonal antibodies Clinical Significance
Monoclonal antibodies Clinical Significance
 
Hybridomatechnology 160204054435
Hybridomatechnology 160204054435Hybridomatechnology 160204054435
Hybridomatechnology 160204054435
 
Monoclonal
MonoclonalMonoclonal
Monoclonal
 
Monoclonal antibody, Application of Monoclonal Antibody, Uses
Monoclonal antibody, Application of Monoclonal Antibody, Uses Monoclonal antibody, Application of Monoclonal Antibody, Uses
Monoclonal antibody, Application of Monoclonal Antibody, Uses
 
Hybridoma technology
Hybridoma technology Hybridoma technology
Hybridoma technology
 

More from ShafqatJaffer786

More from ShafqatJaffer786 (20)

electrophoresis .pptx
electrophoresis .pptxelectrophoresis .pptx
electrophoresis .pptx
 
Blots.ppt
Blots.pptBlots.ppt
Blots.ppt
 
Bloting techniques.pptx
Bloting techniques.pptxBloting techniques.pptx
Bloting techniques.pptx
 
Vaccine production techniques.pptx
Vaccine production techniques.pptxVaccine production techniques.pptx
Vaccine production techniques.pptx
 
spleen.pptx
spleen.pptxspleen.pptx
spleen.pptx
 
RIA.pptx
RIA.pptxRIA.pptx
RIA.pptx
 
Probes .pptx
Probes .pptxProbes .pptx
Probes .pptx
 
secondary lymphoid organ.pptx
secondary lymphoid organ.pptxsecondary lymphoid organ.pptx
secondary lymphoid organ.pptx
 
primary Lymphatic .pptx
primary Lymphatic .pptxprimary Lymphatic .pptx
primary Lymphatic .pptx
 
phagocytosis.pptx
phagocytosis.pptxphagocytosis.pptx
phagocytosis.pptx
 
patteren recognize system .pptx
patteren recognize system .pptxpatteren recognize system .pptx
patteren recognize system .pptx
 
lymph nodes.pptx
lymph nodes.pptxlymph nodes.pptx
lymph nodes.pptx
 
Introduction Immunology .pptx
Introduction Immunology .pptxIntroduction Immunology .pptx
Introduction Immunology .pptx
 
Immunology NK cell.pptx
Immunology NK cell.pptxImmunology NK cell.pptx
Immunology NK cell.pptx
 
Immunology MHC.pptx
Immunology MHC.pptxImmunology MHC.pptx
Immunology MHC.pptx
 
Immunology inflamation.pptx
Immunology inflamation.pptxImmunology inflamation.pptx
Immunology inflamation.pptx
 
Immunology Hypersensitivity.pptx
Immunology Hypersensitivity.pptxImmunology Hypersensitivity.pptx
Immunology Hypersensitivity.pptx
 
Immunology Autoimmunity.pptx
Immunology Autoimmunity.pptxImmunology Autoimmunity.pptx
Immunology Autoimmunity.pptx
 
Immunology Antibody .pptx
Immunology Antibody .pptxImmunology Antibody .pptx
Immunology Antibody .pptx
 
Immunology complementary system .pptx
Immunology complementary system .pptxImmunology complementary system .pptx
Immunology complementary system .pptx
 

Recently uploaded

MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 

Recently uploaded (20)

MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 

Hybridoma .pptx

  • 1.
  • 2. MONOCLONAL ANTIBODY=singal type of antibody ,directed against specific epitope. POLYCLONAL ANTIBODY=in response to an antigen(with several different epitopes),B cells gear up and produce many different antibodies.this type of antibody which can react with same antigen are called as polyclonal antibodies.
  • 3.  B-CELLS+MYLEOMA=HYBRIDOMA andThe production of monoclonal antibodies by the hybrid cells is referred to as hybridoma technology.
  • 4. Georges Kohler CesarMilstein Niels Jerne The production of monoclonal antibodies was invented by Cesar Milstein and Georges Kohler in 1975.they shared the nobel prize of 1984 for medicine and physiology with Neils Jerne, who made other contribution to immunology and the term hybridoma was coined by leonard herzenberg in Cesar Milstein’s laboratory in 1976/1977
  • 5. Antibody producing lymphocyte B cell are isolated from the spleen cell of mouse immunized against a specific antigen Single myeloma cell is a bone marrow tumour cells of multiplying indefinitely. Fused hybrid cells or hybridoma have the antibody producing capability inherited from lymphocytes and have the ability to grow continuously or immortal like malignant cancer cells.
  • 6. 1. Immunization of a mouse 2. Isolation of B cells from the spleen 3. Cultivation of myeloma cells 4. Fusion of myeloma and B cells 5. Separation of cell lines 6. Screening of suitable cell lines 7. in vitro (a) or in vivo (b) multiplication 8. Harvesting
  • 7. 1. Immunize a rabbit through repeated injection of a specific antigen for the production of specific antibody, facilitated due to proliferation of the desired B cells. 2. Produce tumors in a mouse or a rabbit. 3. Culture separately the spleen cells that produce specific antibodies and the myeloma cells that produce tumors 4. Myeloma cells cannot synthesize antibodies as they lack HGPRT gene required for the synthesize the enzyme, hypoxanthine guanine phosphoribosyl transferase
  • 8. • Fusion of spleen cells to myeloma cells is induced using polyethylene glycol (PEG), to produce hybridoma • Hybridomas are grown in selective hypoxanthine aminopterin thymidine (HAT) medium. • HAT medium contains a drug, aminopterin that blocks one pathway for nucleotide synthesis, making the cells dependent on another pathway that needs HGPRT enzyme, which is absent in myeloma cells. • Myeloma cells that do not fuse with B cells will die. • B cells that do not fuse will also die because they lack tumorigenic property of immortal growth.
  • 9.
  • 10.  Select desired hybridoma for cloning and antibody production  Prepare single cell colonies that can grow and use them to screen of antibody producing hybridomas  Only one in several hundred cell hybrids will produce antibodies of the desired specificity  Culture selected hybridoma cells for the production of monoclonal antibodies in large quantities  Hybridoma cells can be frozen for future use or can be injected in the body of an animal, so that antibodies will be produced in the body and recovered later from the body fluid.
  • 11. Monoclonal antibody truely represent a homogeneous state of a single molecular species. Each monoclonal antibody is specific for a given antigenic determinant and there are wide range of aaplications of monoclonal antibodies. It is possible to select for specific epitope specifities and generate antibodies against a wider range of antigenic determinants.
  • 12.  Hybridoma technology is laborious and time consuming.  Mabs are produced against a single antigenic determinant ,hence they do not differentiate the molecule as a whole . Sometime they may be incapable of distinguishing groups of different molecule also.  Mice used in Mab production carry several viruses(adeno viruses ,hepatic viruses).the presence of these viruses has been detected in hybridomas.this posses a great danger there is no guarantee that Mab is totally virus free, despite the purification .
  • 13.  Diagnosis of HIV virus  The test of HIV infection is based on detecting the presence of HIV antibody in the patient’s blood serum
  • 14. a) HIV antigen is attached to the plate. b) Patients serum passed over the plate. Any HIV antibody in the patients serum will attached to the antigen already on the plate. c) A second antibody which is specific to the HIV antibody is passed over the plate. This antibody will attach to the concentrated HIV antibody on the plate. This second antibody has an enzyme attached to its structure. d) Chromagen dye is passed over the complex of concentrated HIV antibody/conjugated antibody. e) The enzyme will turn the chromagen to a more intense colour. The more intense the colour, the greater the HIV antibody level. This would be the a positive result for a HIV test.
  • 15.  Identification of ABO blood groups.  Detection of pregnancy by assaying of hormones with monoclonals,antibodies.  Detection of pathogen.  Separation of one substance from a mixture of very simmilar molecules . monoclonal antibodies are used in the diagnostic immaging of diseases,and this technique is referred as immunoscintigraphy.
  • 16. Monoclonal antibodies use as immunotoxins- toxins +Mabs=immunotoxins ,used in therapy. RICIN- derived from castor oil plant,composed of two polypeptide chains( A and B),held together by disulfide linkage. The B chain of ricin bind to the cell surface.this binding facilitates the A chain of ricin to enter the cell and inhibit the function of ribosomes(i.e. Biosynthesis of all protein is blocked).this result in death of cells.
  • 17.  RICIN can be subjected to oxidation to separate to A and B chains. The toxic A chain can be conjugated to Mab that is specific to cancer cells.  The tumor specific Mab bound to A chain of ricin binds to cancer cells and not to normal cells . Once the A chain enters the cells ,it blocks ribosomal functions leading to the death of cancer cells.
  • 18.
  • 19.  Monoclonal antibody in drug delivery-the drugs can be coupled with monoclonal antibody(directed against a cell surface antigen of the cells,say a tumor ) and specifically targetted to reach the site of action.  In the treatment of certain diseases ,a prodrug(an inactive form of drug)can be used.this can be enzymatically converted to active drug inthe target tissues.the enzyme that convert prodrug to drug is coupled with Mab.that is directed against a specific cell surface antigen this approach is referred as antibody directed pro drug therapy(ADEPT).e.g alkaline phosphatase used for the conversion of phosphate drugs.
  • 20.
  • 21. A great majority of natural death are due to a blockage in coronary or cerebral artery by a blood clot (Thrombus).fibrin is a major constituent of blood clot which get dissolved by plasmin. Plasmin in turn is form by the activation of plasminogen by plasminogen activator. monoclonal antibody directed against fibrin can be coupled to tissue plasminogen activator and used for degradation of blood clot .
  • 22.
  • 23.  The radioisotope can be coupled to monoclonal antibodies that ae directed againsttumor cells this allows the cocentration of radioactivity at desired site and very efficient killing of target cells (tumor cells).  The advantage with radioimmunotherapy is that conjugated complex need not penetrate the cells,as is required in immunotoxin therapy disadvantage is that neighbouring normal cells also get damaged or killed.  This can be minimised by using radioisotope with short half lives .yttrium -90 with a half life span of 64hrs. Due to shortage in supply of yttrium,indium 111 is more commonly used and they should have half life and decay bi-product should be inert.
  • 24.  By using affinity chromatography technique Mabs can be used for the purification of protein e.g.fetoprotein and interferon.  Identification of previously unknown antigen.  Fluorescent labelled Mabs are used for identification ,isolation of cells displaying a specific antigen on their surface.  Mabs have been used to isolate mRNAs encoding the protein to which Mabs are specific.
  • 25.  The antibody enzymes ,appropriately regarded as abzymes ,are catalytic antibodies.  It should be possible to generate such abzymes that catalyze reactions for which no natural enzyme exist.